Healthy Volunteer Clinical Trial
Official title:
High-Density Direct Current Brain Polarization
Background:
- Direct current (DC) brain polarization is a technique in which very weak electricity is
applied to the head. Doctors have used DC polarization for many years on patients and
healthy people with no known serious side effects. Earlier, researchers found that DC
polarization can temporarily improve the ability of healthy people to think of certain
words.
- A disadvantage of existing methods of DC polarization is that they use large electrodes
and the current spreads over a large area of the brain. This makes it difficult to
target particular brain areas. High-density DC polarization uses several small
electrodes to focus the current in a small area of the brain. This study will test
high-density DC polarization for the first time in humans.
Objectives:
- To see how well high-density direct current polarization works in the brain.
- To test a new method of performing direct current brain polarization.
Eligibility:
- Healthy, right-handed adults, ages 18 and older, who have no history of neurological or
psychiatric illnesses.
Design:
- After an initial screening visit with clinical examination, participants may be assigned
to one or both experiments of the study.
- Experiment 1: Participants will have electrodes placed on the left side of their heads,
and will be asked to say aloud as many words as they can think of that begin with
certain letters. After the high-density DC polarization current is turned on and run for
10 minutes, participants will say words beginning with a different set of letters and
perform reaction time and thinking speed tests. Some participants will receive real
polarization and others will not, although all participants will be told that they are
receiving the polarization.
- Experiment 2: Participants will have DC brain polarization performed with transcranial
magnetic stimulation (TMS), which uses magnetic pulses to activate nerve cells in the
brain. We will use TMS to help us understand how far the effect of DC polarization
spreads in the brain. After attaching electrodes to a point on the scalp above the ear,
researchers will give about 50 TMS pulses to five different places near this area. These
pulses will produce some painless muscle twitches in the hand or arm. The TMS pulses
will be followed by the DC brain polarization, and then by another set of TMS pulses to
see if there are any differences in muscle response.
Objective:
The principal objectives are: 1) to explore the effectiveness of anodal high-density direct
current (HDDC) stimulation of the brain; and 2) test the focality of the technique.
Study Population:
Up to 81 healthy volunteers over the age of 18 will be enrolled.
Design:
We will perform three studies:
1. A parallel trial of anodal and sham HDDC delivered to the lateral prefrontal area,
2. An exploratory evaluation of the focality of HDDC in the motor cortex and
3. A study to determine whether HDDC can be better targeted using a finite element model
(FEM) based on the individual subject's MRI scan (obtained as part of the study).
Outcome Measures:
The primary outcome measures are the effect of anodal HDDC (relative to sham) on category
verbal fluency, and the decay in the HDDC-induced change in corticospinal output excitability
with distance from the active electrode. Performance on the California Computerized
Assessment Package is included as a secondary safety outcome.
;
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT06326723 -
Investigate the PK, Safety, and Tolerability After Single and Multiple Dose Daridorexant in Chinese Healthy Subjects
|
Phase 1 | |
Recruiting |
NCT00001367 -
Diagnosis and History Study of Patients With Different Neurological Conditions
|
||
Completed |
NCT02699710 -
Effect of Food, Rabeprazole, Methotrexate and Formulation on the Pharmacokinetics (PK) of GDC-0853 and the Effect of GDC-0853 on the PK of Methotrexate in Healthy Subjects
|
Phase 1 | |
Completed |
NCT02231892 -
Repetitive Transcranial Magnetic Stimulation Equipment Testing and Pilot Study
|
N/A | |
Not yet recruiting |
NCT06441916 -
Bioequivalence Study of Dabigatran Etexilate Capsules 150 mg in Healthy Thai Volunteers Under Fasting Conditions
|
Phase 1 | |
Completed |
NCT03771586 -
A Study to Assess the Electrophysiology, Safety, Tolerability, and Pharmacokinetics of SAGE-718 Using a Ketamine Challenge in Healthy Subjects
|
Phase 1 | |
Not yet recruiting |
NCT06337422 -
Bioequivalence Study of Generic Celecoxib 200 mg Capsules
|
Phase 1 | |
Completed |
NCT03302182 -
Bioequivalence Study of Ritonavir Versus NORVIR in Healthy Chinese Subjects
|
Phase 1 | |
Completed |
NCT05049343 -
Study of SAGE-904 Using a Ketamine Challenge to Evaluate Electrophysiology, Safety, Tolerability, and Pharmacokinetics in Healthy Participants
|
Phase 1 | |
Recruiting |
NCT01629108 -
Normal Values in Hearing and Balance Testing
|
||
Completed |
NCT02947854 -
Study to Assess Safety, Tolerability and Immune Response of Fimaporfin-induced Photochemical Internalisation of Antigen/Adjuvant
|
Phase 1 | |
Completed |
NCT02534870 -
Pharmacokinetics and Safety of the Co-administration of ABT-450/Ritonavir/ABT-267 (ABT-450/r/ABT-267) and ABT-333 in Healthy Chinese Subjects
|
Phase 1 | |
Completed |
NCT02224053 -
Drug-Drug Interaction Study With AZD9291 and Omeprazole in Healthy Volunteers
|
Phase 1 | |
Completed |
NCT01697436 -
A Bioequivalence Study of an Oral Solution of Copegus (Ribavirin) Compared to Copegus Tablets
|
Phase 1 | |
Completed |
NCT01711762 -
A Pharmacokinetics Study of Radioactive-Labeled GDC-0973 in Healthy Male Volunteers
|
Phase 1 | |
Completed |
NCT01684891 -
A 28-Day Pharmacokinetics Study of RG1662 in Healthy Male Volunteers
|
Phase 1 | |
Completed |
NCT01676584 -
A Study of Single Dose RO6811135 in Healthy Volunteers
|
Phase 1 | |
Completed |
NCT01461967 -
A Study on Safety, Pharmacokinetics and Pharmacodynamics of RO5508887 in Healthy Volunteers
|
Phase 1 | |
Completed |
NCT01414881 -
Study to Assess the Effects of Mipomersen on Lipid and Lipoprotein Metabolism in Healthy Subjects
|
Phase 1 | |
Completed |
NCT01579149 -
A Phase I Dose Escalation Study of Plerixafor in Healthy Subjects of Japanese Descent
|
Phase 1 |